5-methylcytosine has been researched along with Animal Mammary Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amant, F; Boeckx, B; Carell, T; Carmeliet, P; Coleman, M; D'Anna, F; Ghesquière, B; Hermans, E; Kristensen, VN; Kuchnio, A; Lambrechts, D; Mazzone, M; Peng Koh, K; Ploumakis, A; Schoonjans, L; Steinbacher, J; Thienpont, B; Van Dyck, L; Zhao, H | 1 |
1 other study(ies) available for 5-methylcytosine and Animal Mammary Carcinoma
Article | Year |
---|---|
Tumour hypoxia causes DNA hypermethylation by reducing TET activity.
Topics: 5-Methylcytosine; Animals; Cell Proliferation; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Female; Gene Silencing; Genes, Tumor Suppressor; Humans; Male; Mammary Neoplasms, Animal; Mice; Mixed Function Oxygenases; Oxidation-Reduction; Oxygen; Promoter Regions, Genetic; Proto-Oncogene Proteins; Stromal Cells; Tumor Hypoxia | 2016 |